Overview Financials News + Filings Key Docs Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
CNL Strategic Capital, LLC
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/21/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
08/21/2023 |
8-K
| Other Events Interactive Data |
08/10/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
07/24/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
07/24/2023 |
8-K
| Quarterly results |
07/11/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
06/28/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
06/15/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
06/15/2023 |
8-K
| Other Events Interactive Data |
05/15/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/08/2023 |
4
| SUBASI SAFAK (Senior Vice President) has filed a Form 4 on CNL Strategic Capital, LLC
Txns:
| Bought 303 shares
@ $0 |
|
05/08/2023 |
4
| Drury Paul W (Senior Managing Director) has filed a Form 4 on CNL Strategic Capital, LLC
Txns:
| Bought 2,248 shares
@ $33.36, valued at
$75k
|
|
05/08/2023 |
4
| SENEFF JAMES M JR (Director) has filed a Form 4 on CNL Strategic Capital, LLC
Txns:
| Sold 303 shares
@ $0 |
|
04/24/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
04/24/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
04/21/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
04/21/2023 |
8-K
| Quarterly results |
04/13/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
03/29/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/27/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
03/27/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data
Docs:
|
"CNL Strategic capital ACQUIRES majority stake in TacMED SOluTIONS March 27, 2023 — CNL Strategic Capital, LLC acquired a majority equity stake and made a concurrent debt investment in TacMed Solutions . At the closing of the transaction, all of the remaining TacMed equity is owned by members of TacMed’ s executive team and its founder. This is the 12th company in CNL Strategic Capital’ s portfolio. Founded in 2003 and headquartered in Anderson, South Carolina, TacMed designs, develops and manufactures medical products that equip, train and protect professionals in pre-hospital, emergency trauma situations. TacMed’ s suite of traumatic injury products, hemorrhage control tourniquets, immobilization tools and critical care kits serve first responders, military, law enforcement and civilian p..." |
|
03/17/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
03/17/2023 |
8-K
| Other Events Interactive Data |
02/24/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
02/24/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
12/16/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
12/16/2022 |
8-K
| Quarterly results |
11/18/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
11/18/2022 |
8-K
| Quarterly results |
11/14/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
10/21/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
|
|
|